(Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -5.68%5.13B | 30.52%20.28B | 36.52%15.84B | 42.03%10.84B | 32.14%5.44B | 52.40%15.54B | 53.82%11.6B | 53.12%7.63B | 70.68%4.12B | 38.44%10.19B |
Operating income | 30.52%20.28B | 42.03%10.84B | 52.40%15.54B | 53.12%7.63B | 38.44%10.19B | |||||
Cost of sales | ---- | -24.54%-14.83B | ---- | -37.67%-8.01B | ---- | -52.57%-11.91B | ---- | -54.32%-5.82B | ---- | -44.45%-7.8B |
Operating expenses | -24.54%-14.83B | -37.67%-8.01B | -52.57%-11.91B | -54.32%-5.82B | -44.45%-7.8B | |||||
Gross profit | -3.96%1.28B | 50.13%5.45B | 59.51%4.31B | 56.00%2.83B | 52.94%1.33B | 51.84%3.63B | 49.28%2.7B | 49.39%1.82B | 39.87%869.79M | 21.87%2.39B |
Selling expenses | ---- | -35.30%-1.26B | ---- | -33.71%-535.87M | ---- | -64.65%-932.88M | ---- | -64.41%-400.76M | ---- | -31.62%-566.57M |
Administrative expenses | ---- | -88.00%-2.21B | ---- | -71.97%-967.91M | ---- | -11.79%-1.18B | ---- | -19.65%-562.84M | ---- | -48.98%-1.05B |
Impairment and provision | ---- | -158.44%-225.35M | ---- | -225.29%-122.25M | ---- | -3,482.33%-87.19M | ---- | -297.32%-37.58M | ---- | -103.28%-2.43M |
-Other impairment is provision | ---- | -158.44%-225.35M | ---- | -225.29%-122.25M | ---- | -3,482.33%-87.19M | ---- | -297.32%-37.58M | ---- | -103.28%-2.43M |
Special items of operating profit | ---- | 8.16%672.73M | ---- | 9.28%308.62M | ---- | -21.29%621.96M | ---- | -41.31%282.42M | ---- | 85.96%790.23M |
Operating profit | 17.83%2.42B | 38.12%1.51B | 31.79%2.05B | 9.52%1.1B | 17.78%1.56B | |||||
Financing cost | ---- | -20.04%-158.41M | ---- | -1.88%-73.92M | ---- | -10.28%-131.97M | ---- | -31.33%-72.56M | ---- | 9.54%-119.67M |
Earning before tax | -21.08%558.22M | 17.67%2.26B | 43.92%2.1B | 40.69%1.44B | 38.83%707.32M | 33.58%1.92B | 17.02%1.46B | 8.25%1.02B | 38.40%509.49M | 20.82%1.44B |
Tax | ---- | -67.43%-421.7M | ---- | -131.07%-257.3M | ---- | -95.40%-251.86M | ---- | 4.83%-111.35M | ---- | 7.09%-128.89M |
After-tax profit from continuing operations | 10.17%1.84B | 29.66%1.18B | 27.49%1.67B | 10.09%912.62M | 24.50%1.31B | |||||
Earning after tax | -24.75%486.74M | 10.17%1.84B | 33.59%1.73B | 29.66%1.18B | 45.34%646.78M | 27.49%1.67B | 16.11%1.29B | 10.09%912.62M | 30.87%445M | 24.50%1.31B |
Minority profit | ---- | -2,267.62%-90.24M | ---- | -373.09%-18.64M | ---- | -91.69%4.16M | ---- | -61.77%6.83M | ---- | 682.00%50.09M |
Profit attributable to shareholders | -20.70%515.67M | 15.86%1.93B | 36.68%1.77B | 32.70%1.2B | 46.43%650.26M | 32.23%1.66B | 1.3B | 11.68%905.79M | 31.16%444.06M | 20.47%1.26B |
Basic earnings per share | 9.43%0.58 | 31.03%0.38 | 32.50%0.53 | 11.54%0.29 | 17.65%0.4 | |||||
Diluted earnings per share | 13.04%0.52 | 32.00%0.33 | 31.43%0.46 | 13.64%0.25 | 20.69%0.35 | |||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | -- | -- | Ernst & Young | -- | -- | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data